CDR2L antibody (N-Term)

Catalog No. ABIN927767

The Rabbit Polyclonal anti-CDR2L antibody has been validated for WB. It is suitable to detect CDR2L in samples from Human.

Quick Overview for CDR2L antibody (N-Term) (ABIN927767)

Target: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CDR2L antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-CDR2L Antibody

Binding Specificity: N-Term

Purification: Purified

Immunogen: CDR2 L antibody was raised in rabbit using the N terminal of CDR2 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

CDR2L Blocking Peptide, catalog no. 33R-6378, is also available for use as a blocking control in assays to test for specificity of this CDR2L antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for CDR2L

Target: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Alternative Name: CDR2L

Background: The function of CDR2L remains unknown. Synonyms: Polyclonal CDR2L antibody, Anti-CDR2L antibody, cerebellar degeneration-related protein 2-like antibody, HUMPPA antibody.